We found that TICs were sensitive to the broad ALDH inhibitor disulfiram compared to adherent cells, and that disulfiram delivered intraperitoneally could prevent relapse in a post-surgery, post-chemotherapy ovarian cancer mouse model (15). This evidence concerns the gene LDHA and ovarian cancer.